Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Marton

Showing results (161-170 of 312) with videos related to

Pageof 32
Sort By:
Molecular Pharmacology|August 1, 1992
Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogsL Ghoda, H S Basu, C W Porter, et al.
Life Sciences|December 1, 1973
Cholesterol in cerebrospinal fluid of brain tumor patientsJ H Fleisher, L J Marton, N R Bachur, et al.
The Journal of Biological Chemistry|December 21, 2002
Functional interactions between yeast translation eukaryotic elongation factor (eEF) 1A and eEF3Monika Anand, Kalpana Chakraburtty, Matthew J Marton, et al.
The Biochemical Journal|December 3, 2011
Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genesYu Wu, Nora Steinbergs, Tracy Murray-Stewart, et al.
Cancer Research|December 15, 1987
Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cellsM Bakic, D Chan, E J Freireich, et al.
Cancer Research|April 1, 1983
Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithineR Bjerkvig, S M Oredsson, L J Marton, et al.
Journal of Neural Transmission|January 1, 1985
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm studyW Birkmayer, J Knoll, P Riederer, et al.
Proceedings of the Clinical Dialysis and Transplant Forum|November 18, 1978
Uremic polyamine dysmetabolismR A Campbell, D P Grettie, F Bartos, et al.
International Journal of Cancer|September 30, 1992
Production of stable phenotypes from 9L rat brain tumor multicellular spheroids treated with 1,3-bis(2-chloroethyl)-1-nitrosoureaM H Barcellos-Hoff, P A Linfoot, L J Marton, et al.
Scientific Reports|January 16, 2019
Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS AssaysPing Qiu, Christian H Poehlein, Matthew J Marton, et al.
Pageof 32

Showing results (161-170 of 312) with videos related to

Sort By:
Pageof 32
Molecular Pharmacology|August 1, 1992
Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogsL Ghoda, H S Basu, C W Porter, et al.
Life Sciences|December 1, 1973
Cholesterol in cerebrospinal fluid of brain tumor patientsJ H Fleisher, L J Marton, N R Bachur, et al.
The Journal of Biological Chemistry|December 21, 2002
Functional interactions between yeast translation eukaryotic elongation factor (eEF) 1A and eEF3Monika Anand, Kalpana Chakraburtty, Matthew J Marton, et al.
The Biochemical Journal|December 3, 2011
Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genesYu Wu, Nora Steinbergs, Tracy Murray-Stewart, et al.
Cancer Research|December 15, 1987
Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cellsM Bakic, D Chan, E J Freireich, et al.
Cancer Research|April 1, 1983
Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithineR Bjerkvig, S M Oredsson, L J Marton, et al.
Journal of Neural Transmission|January 1, 1985
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm studyW Birkmayer, J Knoll, P Riederer, et al.
Proceedings of the Clinical Dialysis and Transplant Forum|November 18, 1978
Uremic polyamine dysmetabolismR A Campbell, D P Grettie, F Bartos, et al.
International Journal of Cancer|September 30, 1992
Production of stable phenotypes from 9L rat brain tumor multicellular spheroids treated with 1,3-bis(2-chloroethyl)-1-nitrosoureaM H Barcellos-Hoff, P A Linfoot, L J Marton, et al.
Scientific Reports|January 16, 2019
Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS AssaysPing Qiu, Christian H Poehlein, Matthew J Marton, et al.
Pageof 32